Palo Alto, CA, United States of America

Melinda Thomas

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Octave Bioscience, Inc.. Active years: 2023.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melinda Thomas: Innovator in Multiple Sclerosis Assessment

Introduction

Melinda Thomas is a notable inventor based in Palo Alto, CA (US). She has made significant contributions to the field of medical technology, particularly in the assessment of multiple sclerosis activity. Her innovative work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Melinda holds 1 patent titled "Methods for assessment of multiple sclerosis activity." This patent provides markers useful for determining multiple sclerosis activity in a human subject. It also includes kits for measuring quantitative expression values of these markers. Additionally, her patent encompasses computer systems and software embodiments of predictive models for scoring and determining multiple sclerosis activity based on the quantitative expression values of the markers.

Career Highlights

Melinda is currently employed at Octave Bioscience, Inc., where she continues to develop innovative solutions for healthcare challenges. Her work focuses on enhancing the understanding and management of multiple sclerosis through advanced assessment methods.

Collaborations

Throughout her career, Melinda has collaborated with esteemed colleagues, including Michael Graham Walker and William A. Hagstrom. These partnerships have contributed to the advancement of her research and the development of her patented technologies.

Conclusion

Melinda Thomas is a pioneering inventor whose work in multiple sclerosis assessment is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…